Profound Medical/$PROF
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Profound Medical
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Ticker
$PROF
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Mississauga, Canada
Employees
142
ISIN
CA74319B5027
Website
Profound Medical Metrics
BasicAdvanced
$177M
-
-$1.22
0.25
-
Price and volume
Market cap
$177M
Beta
0.25
52-week high
$11.42
52-week low
$3.90
Average daily volume
52K
Financial strength
Current ratio
11.315
Quick ratio
9.896
Long term debt to equity
9.1
Total debt to equity
9.614
Profitability
EBITDA (TTM)
-35.502
Gross margin (TTM)
67.64%
Net profit margin (TTM)
-269.39%
Operating margin (TTM)
-306.45%
Effective tax rate (TTM)
0.00%
Revenue per employee (TTM)
$80,000
Management effectiveness
Return on assets (TTM)
-38.54%
Return on equity (TTM)
-66.36%
Valuation
Price to revenue (TTM)
13.253
Price to book
4.77
Price to tangible book (TTM)
4.79
Price to free cash flow (TTM)
-5.778
Free cash flow yield (TTM)
-17.31%
Free cash flow per share (TTM)
-103.84%
Growth
Revenue change (TTM)
75.01%
Earnings per share change (TTM)
-4.44%
3-year revenue growth (CAGR)
16.38%
3-year earnings per share growth (CAGR)
-7.20%
10-year earnings per share growth (CAGR)
-27.76%
What the Analysts think about Profound Medical
Analyst ratings (Buy, Hold, Sell) for Profound Medical stock.
Profound Medical Financial Performance
Revenues and expenses
Profound Medical Earnings Performance
Company profitability
Profound Medical News
AllArticlesVideos
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
GlobeNewsWire·2 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
Accesswire·2 months ago
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Profound Medical stock?
Profound Medical (PROF) has a market cap of $177M as of June 30, 2025.
What is the P/E ratio for Profound Medical stock?
The price to earnings (P/E) ratio for Profound Medical (PROF) stock is 0 as of June 30, 2025.
Does Profound Medical stock pay dividends?
No, Profound Medical (PROF) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Profound Medical dividend payment date?
Profound Medical (PROF) stock does not pay dividends to its shareholders.
What is the beta indicator for Profound Medical?
Profound Medical (PROF) has a beta rating of 0.25. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.